Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.
Walden Biosciences's investors include ARCH Venture Partners, Mass General Brigham Ventures, ATEM Capital Fund LP, UCB Ventures, Eurofarma Ventures.
Walden Biosciences is headquartered in Cambridge, United States.
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.
Walden Biosciences is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Walden Biosciences — Funding & Investors." VCBacked, October 1, 2023, https://www.vcbacked.co/company/walden-biosciences. Accessed July 21, 2026.
VCBacked. (2023). Walden Biosciences — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/walden-biosciences
{{cite web |title=Walden Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/walden-biosciences |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated